BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11098056)

  • 1. Transforming growth factor-beta 1-mediated inhibition of the flk-1/KDR gene is mediated by a 5'-untranslated region palindromic GATA site.
    Minami T; Rosenberg RD; Aird WC
    J Biol Chem; 2001 Feb; 276(7):5395-402. PubMed ID: 11098056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor.
    Patterson C; Perrella MA; Hsieh CM; Yoshizumi M; Lee ME; Haber E
    J Biol Chem; 1995 Sep; 270(39):23111-8. PubMed ID: 7559454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between hex and GATA transcription factors in vascular endothelial cells inhibits flk-1/KDR-mediated vascular endothelial growth factor signaling.
    Minami T; Murakami T; Horiuchi K; Miura M; Noguchi T; Miyazaki J; Hamakubo T; Aird WC; Kodama T
    J Biol Chem; 2004 May; 279(20):20626-35. PubMed ID: 15016828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human KDR/flk-1 gene contains a functional initiator element that is bound and transactivated by TFII-I.
    Wu Y; Patterson C
    J Biol Chem; 1999 Jan; 274(5):3207-14. PubMed ID: 9915861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.
    Gerber HP; Condorelli F; Park J; Ferrara N
    J Biol Chem; 1997 Sep; 272(38):23659-67. PubMed ID: 9295307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development.
    Kappel A; Schlaeger TM; Flamme I; Orkin SH; Risau W; Breier G
    Blood; 2000 Nov; 96(9):3078-85. PubMed ID: 11049987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear protein interactions with the human KDR/flk-1 promoter in vivo. Regulation of Sp1 binding is associated with cell type-specific expression.
    Patterson C; Wu Y; Lee ME; DeVault JD; Runge MS; Haber E
    J Biol Chem; 1997 Mar; 272(13):8410-6. PubMed ID: 9079666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells.
    Mandriota SJ; Menoud PA; Pepper MS
    J Biol Chem; 1996 May; 271(19):11500-5. PubMed ID: 8626709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
    Takagi H; King GL; Ferrara N; Aiello LP
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1311-21. PubMed ID: 8641834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J; Morita I; Onodera M; Murota SI
    J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells.
    Otani A; Takagi H; Suzuma K; Honda Y
    Circ Res; 1998 Mar; 82(5):619-28. PubMed ID: 9529167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear stress induces expression of vascular endothelial growth factor receptor Flk-1/KDR through the CT-rich Sp1 binding site.
    Abumiya T; Sasaguri T; Taba Y; Miwa Y; Miyagi M
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):907-13. PubMed ID: 12067897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the endothelium-specific murine vascular endothelial growth factor receptor-2 (Flk-1) promoter.
    Rönicke V; Risau W; Breier G
    Circ Res; 1996 Aug; 79(2):277-85. PubMed ID: 8756005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells.
    Patterson C; Perrella MA; Endege WO; Yoshizumi M; Lee ME; Haber E
    J Clin Invest; 1996 Jul; 98(2):490-6. PubMed ID: 8755661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.
    Shen BQ; Lee DY; Gerber HP; Keyt BA; Ferrara N; Zioncheck TF
    J Biol Chem; 1998 Nov; 273(45):29979-85. PubMed ID: 9792718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence.
    Hata Y; Duh E; Zhang K; Robinson GS; Aiello LP
    J Biol Chem; 1998 Jul; 273(30):19294-303. PubMed ID: 9668119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappaB and cAMP response element binding protein mediate opposite transcriptional effects on the Flk-1/KDR gene promoter.
    Illi B; Puri P; Morgante L; Capogrossi MC; Gaetano C
    Circ Res; 2000 Jun; 86(12):E110-7. PubMed ID: 10864920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
    McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.